AETERNA ZENTARIS Trademark

Trademark Overview

On Thursday, June 17, 2004, a trademark application was filed for AETERNA ZENTARIS with the United States Patent and Trademark Office. The USPTO has given the AETERNA ZENTARIS trademark a serial number of 78437128. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 27, 2017. This trademark is owned by Aeterna Zentaris Inc.. The AETERNA ZENTARIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of hematological diseases, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparations used for the treatment of ophtalmological disorders, pharmaceutical preparations used for the treatment of reproductive system disorders, pharmaceutical preparations used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myo...
aeterna zentaris

General Information

Serial Number78437128
Word MarkAETERNA ZENTARIS
Filing DateThursday, June 17, 2004
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, November 27, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of hematological diseases, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparations used for the treatment of ophtalmological disorders, pharmaceutical preparations used for the treatment of reproductive system disorders, pharmaceutical preparations used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparations used for the treatment of benign prostatic hyperplasia (BPH), pharmaceutical preparations used for the treatment of tropical diseases, pharmaceutical preparations used for the treatment of infectious disease, pharmaceutical preparations used for the treatment of leishmaniasis, pharmaceutical preparations used for the treatment of obesity, pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes, pharmaceutical preparations containing conjugated and non-conjugated cytotoxic products used to selectively and specifically target certain types of cancer; pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform used for the treatment of certain types of cancer and endocrine disorders, pharmaceutical preparations based on bombesin antagonist platform used for the treatment of certain types of cancer, pharmaceutical preparations based on inhibitors of the Akt pathway used for the treatment of certain types of cancer, pharmaceutical preparations based on angiogenesis inhibitors platform with multiple mechanisms of action used for the treatment of certain types of cancer, pharmaceutical preparations used to induce apoptosis, pharmaceutical preparations used to stimulate growth hormone secretagogue (GHS)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 23, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAeterna Zentaris Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressQuebec G1P 4P5
CA

Trademark Events

Event DateEvent Description
Monday, November 27, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, November 27, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, June 1, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 1, 2017INQUIRY AS TO SUSPENSION MAILED
Monday, May 1, 2017SUSPENSION INQUIRY WRITTEN
Tuesday, November 1, 2016LETTER OF SUSPENSION MAILED
Tuesday, November 1, 2016SUSPENSION LETTER WRITTEN
Monday, October 31, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 31, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 24, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 1, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 1, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 17, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, May 17, 2016INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 17, 2016SUSPENSION INQUIRY WRITTEN
Tuesday, November 17, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 17, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, November 17, 2015SUSPENSION LETTER WRITTEN
Tuesday, October 27, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 27, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 17, 2015ASSIGNED TO LIE
Monday, September 28, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 1, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 1, 2015INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 1, 2015SUSPENSION INQUIRY WRITTEN
Wednesday, October 1, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 1, 2014LETTER OF SUSPENSION E-MAILED
Wednesday, October 1, 2014SUSPENSION LETTER WRITTEN
Wednesday, September 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 17, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, March 26, 2014NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, March 26, 2014INQUIRY TO SUSPENSION E-MAILED
Wednesday, March 26, 2014SUSPENSION INQUIRY WRITTEN
Wednesday, September 25, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 26, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 26, 2013LETTER OF SUSPENSION E-MAILED
Thursday, September 26, 2013SUSPENSION LETTER WRITTEN
Wednesday, September 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 10, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 10, 2013INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 10, 2013SUSPENSION INQUIRY WRITTEN
Wednesday, October 10, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 10, 2012LETTER OF SUSPENSION E-MAILED
Wednesday, October 10, 2012SUSPENSION LETTER WRITTEN
Tuesday, October 9, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 8, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 8, 2012TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, April 6, 2012NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, April 6, 2012INQUIRY TO SUSPENSION E-MAILED
Friday, April 6, 2012SUSPENSION INQUIRY WRITTEN
Thursday, November 10, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 10, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 6, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 6, 2011LETTER OF SUSPENSION E-MAILED
Thursday, October 6, 2011SUSPENSION LETTER WRITTEN
Wednesday, October 5, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 5, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 5, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 6, 2011NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 6, 2011INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 6, 2011SUSPENSION INQUIRY WRITTEN
Monday, October 25, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 6, 2010LETTER OF SUSPENSION MAILED
Tuesday, October 5, 2010SUSPENSION LETTER WRITTEN
Thursday, September 30, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 30, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 30, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, April 20, 2010INQUIRY AS TO SUSPENSION MAILED
Tuesday, April 20, 2010SUSPENSION INQUIRY WRITTEN
Tuesday, April 20, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, October 20, 2009LETTER OF SUSPENSION MAILED
Monday, October 19, 2009SUSPENSION LETTER WRITTEN
Wednesday, October 14, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 14, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 14, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 15, 2009INQUIRY AS TO SUSPENSION MAILED
Tuesday, April 14, 2009SUSPENSION INQUIRY WRITTEN
Tuesday, April 14, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, October 14, 2008LETTER OF SUSPENSION MAILED
Sunday, October 12, 2008SUSPENSION LETTER WRITTEN
Saturday, October 11, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 11, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 7, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, October 6, 2008INQUIRY AS TO SUSPENSION MAILED
Monday, October 6, 2008SUSPENSION INQUIRY WRITTEN
Wednesday, October 1, 2008LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, April 1, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, March 28, 2008LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, March 28, 2008ASSIGNED TO LIE
Thursday, September 20, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, March 20, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 19, 2006LETTER OF SUSPENSION MAILED
Monday, September 18, 2006SUSPENSION LETTER WRITTEN
Monday, August 7, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 18, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 18, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 14, 2006INQUIRY AS TO SUSPENSION MAILED
Tuesday, February 14, 2006SUSPENSION INQUIRY WRITTEN
Tuesday, August 9, 2005LETTER OF SUSPENSION MAILED
Monday, August 8, 2005SUSPENSION LETTER WRITTEN
Friday, August 5, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 1, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 1, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 7, 2005NON-FINAL ACTION MAILED
Saturday, February 5, 2005NON-FINAL ACTION WRITTEN
Friday, January 21, 2005ASSIGNED TO EXAMINER
Wednesday, June 23, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

zentaris aeterna used preparations pharmaceutical treatment diseases disorders tumors cancer hormonal related